Literature DB >> 12502933

Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'?

Susan C Abraham1, Robb E Wilentz, Charles J Yeo, Taylor A Sohn, John L Cameron, John K Boitnott, Ralph H Hruban.   

Abstract

Pancreaticoduodenectomy (Whipple resection) has evolved into a safe procedure in major high-volume medical centers for the treatment of pancreatic adenocarcinoma and refractory chronic pancreatitis. However, some Whipple resections performed for a clinical suspicion of malignancy reveal only benign disease on pathologic examination. We evaluated the frequency of such Whipple resections without tumor in a large series of pancreaticoduodenectomies and classified the diverse pancreatic and biliary tract diseases present in these specimens. Of 442 Whipple resections performed during 1999-2001, 47 (10.6%) were negative for neoplastic disease and, in 40 cases, had been performed for a clinical suspicion of malignancy. Most Whipple resections revealed benign pancreatic disease, including 8 (17%) alcohol-associated chronic pancreatitis, 4 (8.5%) gallstone-associated pancreatitis, 1 (2.1%) pancreas divisum, 6 (12.8%) "ordinary" chronic pancreatitis of unknown etiology, and 11 (23.4%) lymphoplasmacytic sclerosing pancreatitis. In particular, patients with lymphoplasmacytic sclerosing pancreatitis were all thought to harbor malignancy, whereas only 13 of 19 (68.4%) of Whipple resections showing histologically "ordinary" forms of chronic pancreatitis were performed for a clinical suspicion of malignancy. Benign biliary tract disease, including three cases of primary sclerosing cholangitis, two cases of choledocholithiasis-associated chronic biliary tract disease, and four fibroinflammatory strictures isolated to the intrapancreatic common bile duct, was a common etiology for clinically suspicious Whipple resections (22.5% of cases). Pancreatic intraepithelial neoplasia (PanIN) was a common finding among all pancreata, whether involved by pancreatitis or histologically normal. Overall, PanIN 1A/1B was present in 68.1%, PanIN 2 in 40.4%, and PanIN 3 in just 2.1%. These findings indicate that "benign but clinically suspicious" Whipple resections are relatively common in high-volume centers (9.2%) and reveal a diverse group of clinicopathologically distinctive pancreatic and biliary tract disease.

Entities:  

Mesh:

Year:  2003        PMID: 12502933     DOI: 10.1097/00000478-200301000-00012

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  87 in total

1.  Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer.

Authors:  Yukiko Sugiyama; Yasunari Fujinaga; Masumi Kadoya; Kazuhiko Ueda; Masahiro Kurozumi; Hideaki Hamano; Shigeyuki Kawa
Journal:  Jpn J Radiol       Date:  2012-01-12       Impact factor: 2.374

2.  Conference report: Korea-Japan symposium on autoimmune pancreatitis.

Authors:  Seung Woo Park; Jae Bock Chung; Makoto Otsuki; Myung-Hwan Kim; Jae Hoon Lim; Shigeyuki Kawa; Tetsuhide Ito; Isao Nishimori; Ji Kon Ryu; Kazuichi Okazaki; Kyutaek Lee; Terumi Kamisawa
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

Review 3.  Autoimmune pancreatitis and IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Kensuke Takuma; Naoto Egawa; Koji Tsuruta; Tsuneo Sasaki
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-15       Impact factor: 46.802

4.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

5.  The therapeutic strategy for autoimmune pancreatitis is subject to the endoscopic features of the duodenal papilla.

Authors:  Kensuke Kubota; Atushi Nakajima
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

6.  Hospital readmission after pancreaticoduodenectomy.

Authors:  Dawn M Emick; Taylor S Riall; John L Cameron; Jordan M Winter; Keith D Lillemoe; Joann Coleman; Patricia K Sauter; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 7.  Current surgical management of chronic pancreatitis.

Authors:  Richard H Bell
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

Review 8.  Autoimmune pancreatitis.

Authors:  Andres Gelrud; Steven D Freedman
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

Review 9.  Histopathology of autoimmune pancreatitis: recognized features and unsolved issues.

Authors:  Mari Mino-Kenudson; Gregory Y Lauwers
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

10.  Autoimmune pancreatitis: functional and morphological recovery after steroid therapy.

Authors:  László Czakó; Eva Hegyközi; Attila Pálinkás; János Lonovics
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.